Latest news
Why ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:34:48 GMTIBRX Stock Jumps Overnight: UAE Grants Anktiva Broadest Approval Yet After Founder’s ‘July Birthday News’ Tease - StocktwitsStocktwits · Fri, 07 Aug 2026 17:30:24 GMTIBRX Stock Eyes Green Open Ahead Of Earnings — What Happened With Anktiva Over The Weekend - StocktwitsStocktwits · Fri, 07 Aug 2026 17:00:28 GMTIBRX Stock Reverses Pre-Market Gains After ANKTIVA Combo Shows Stronger Bladder Cancer Responses – Retail Sees Consolidation Before Next Leg Up - StocktwitsStocktwits · Fri, 07 Aug 2026 14:30:08 GMTIBRX Founder Backs Trump’s Psychedelic Push In ‘Transforming’ Health Policy — Flags New Anktiva Breast Cancer Risk Data - StocktwitsStocktwits · Fri, 07 Aug 2026 11:57:05 GMTThe Bull Case For ImmunityBio (IBRX) Could Change Following ANKTIVA’s Broad UAE Approval And Ongoing Losses - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 06:14:28 GMTIBRX Stock Lights Up: Retail Cheers Calls For Trump To ‘Pull The Plug’ On FDA Chief Marty Makary Amid Anktiva Row - StocktwitsStocktwits · Wed, 05 Aug 2026 19:34:17 GMTIBRX Stock Sees Sharp UAE-Driven Jump Followed By Early August Pullback - TradingViewTradingView · Mon, 03 Aug 2026 23:47:46 GMT